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Pleomorphic Carcinoma of the Lung with High Serum Beta-
human Chorionic Gonadotropin Level and Gynecomastia
Although gynecomastia is a well-defined paraneoplastic syndrome in patients with non-
small cell lung cancer, the association with pleomorphic carcinoma has not been reported. 
A 50-yr-old man presented with bilateral gynecomastia and elevated serum beta-human 
chorionic gonadotropin (βhCG) level. Chest tomography showed a mass in the right middle 
lobe. Right middle lobectomy and mediastinal lymph node dissection were performed. 
βhCG levels decreased rapidly after surgery. Histological examination revealed pleomorphic 
carcinoma with positive immunostaining for βhCG. Serum βhCG levels began to increase 
gradually on postoperatively 4th month. Computed tomography detected recurrence and 
chemotherapy was started. After second cycle of chemotherapy, βhCG levels decreased 
dramatically again and tomography showed regression in mass. Patient died 6 months later 
due to brain metastasis. βhCG expression may be associated with aggressive clinical course 
and increased risk of recurrence, also βhCG levels may be used to evaluate therapy 
response in patients with pleomorphic carcinoma. 
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CASE REPORT
Oncology & Hematology
INTRODUCTION
Pleomorphic carcinoma of the lung is defined as a group of poor-
ly differentiated non-small cell carcinoma that contains a com-
ponent of sarcoma or sarcoma-like elements and shows carci-
nomatous as well as spindle and/or giant cell components [1]. 
Pleomorphic component should comprise at least 10% of neo-
plasm. It’s a rare tumor that makes up only 0.1% to 0.4% of all 
malignant lung tumors, and its clinical prognosis is highly un-
predictable [2-4].
  Elevated serum beta-human chorionic gonadotropin (βhCG) 
levels have been reported in 12% of NSCLC patients [5]. When 
immunohistochemical methods are used, βhCG positivity have 
been detected in 28% of the resected specimens [5]. Although 
βhCG production is not seen rarely in NSCLC, clinically signifi-
cant symptoms, e.g. gynecomastia are uncommon. 
  Here we describe a 50-yr-old male patient with pulmonary 
pleomorphic carcinoma producing high levels of βhCG and pre-
senting with gynecomastia.
CASE REPORT
A 50-yr-old man with a history of smoking presented with bilat-
eral gynecomastia and weight loss on December 4, 2008. Physi-
cal examination showed bilateral slightly enlarged breasts. Al-
though his serum AFP level was in normal range, his serum 
βhCG level was found to be elevated (6,500 MIU/mL). Physical 
examination of the testes and testicular ultrasonography did 
not detect any mass formation. Chest radiography revealed a 
right paracardiac opacity. Computed tomography (CT) showed 
a solitary mass in the right middle lobe (Fig. 1). In PET scan, a 
solitary hypermetabolic lesion (SUV: 12), 6 cm in size, was iden-
tified in the right middle lobe. The brain MRI detected no ab-
normalities. After excluding the presence of any middle zone 
tumors and lymph node involvement , excision of right lung le-
sion was planned.
  The pleural cavity was entered through a right thoracotomy 
at the fifth intercostal space. The mass was explored in right mid-
dle lobe. Well-shaped mass located in the right middle lobe was 
seen; frozen section performed during operation identified ma-
lignancy, therefore a decision for right middle lobectomy was 
made. Major and minor fissures were divided free. Middle lobe 
arterial branches were explored and freed circumferentially by 
sharp and gentle blunt dissection and tied with 2-0 silk sutures 
and divided between ligatures. Middle lobe vein was isolated, 
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was dissected free and a TA 30 stapler was used to close the bron-
chus. After the staple line had been placed, a bronchus clamp 
was placed distal to the staples. Right middle lobectomy and 
mediastinal lymph node dissection were performed. Operation 
was finished without complication. 
  Pathological examination of lobectomy material revealed a 
peripherally located, 5 cm-in diameter, cavitary tumoral lesion. 
Microscopically, the tumor consisted mostly of polygonal pleo-
morphic cells, intermingled with few inflammatory cells (Fig. 
2A). There were limited number of carcinoma foci with squa-
moid differentiation. Some non-cohesive multinuclear giant 
tumoral cells (giant cell component without syncytiotropho-
blast) were seen in a few areas. The diagnosis of pleomorphic 
carcinoma was made due to cytokeratin immunopositivity in 
most of the tumor cells. βhCG and PLAP expression was pres-
ent in approximately 40% of the multinuclear giant and polygo-
nal cells on immunohistology, but the tumor cells were nega-
tive for TTF-1 (Fig. 2B, C). There was no tumoral involvement in 
the mediastinal and hilus lymph nodes.
  After surgery, serum βhCG level decreased gradually. At third 
day after operation, sudden loss of conciousness and respirato-
ry distress occured; urgent cranial CT scan was done. Right cer-
ebellar infarction, closure of fourth ventricules and hydroceph-
alus were observed. In emergency conditions suboccipital cra-
niotomy, right cerebellar infarctectomy and ventricular drain-
age were performed, pathology of resected material diagnosed 
cerebellar subacute infarction. Anticoagulant therapy was start-
ed. Tracheostomy and gastrostomy were applied. 
  Serum βhCG levels increased gradually in time during the 
patient’s follow-up suggesting relapse or metastasis (Fig. 3) and 
subsequently a positron emission tomography scan was ob-
tained which revealed a 3×4 cm in size, pleura-based lesion 
with a SUV of 6.2 located in the superior-posterior segment of 
the right hemithorax and FDG positive enlarged mediastinal 
lymph nodes. Histopathological verification of transthorasic 
fine needle aspiration biopsy material was consistent with pleo-
morphic carcinoma. Therefore chemotherapy was started with 
the indication of recurrent lung cancer. After two cycles of cispl-
A C B
Fig. 2. Histopathological pictures of the tumor which represents of the pleomorphic carcinoma. (A) The tumor consists of polygonal tumor cells (H&E), (B) TTF-1 negativity of the 
tumor (upper part of the picture) while non-tumoral lung parenchyma showed TTF-1 positivity, (C) βhCG positivity in the giant multinuclear tumor cells.
Fig. 1. Thorax CT scanning show solitary mass with 5.5×4.5 cm in size in the right 
middle lobe.
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atin-etoposid based chemotherapy, the levels of serum βhCG 
decreased dramatically (Fig. 3) and regression in the size of the 
lesion was observed through CT scan. Four months after the 
start of chemotherapy, the patient presented with headache and 
somnolence. Brain MRI showed multiple metastatic lesions 
with the largest one being 3 cm in diameter and accompanying 
perilesional edema. Antiedema treatment was started and pal-
liative whole brain radiotherapy was performed. The patient 
died 2 months later from respiratory failure due to progression 
of brain metastases and cerebral edema resulting herniation.
DISCUSSION
In the 1999 WHO/International Association for the Study of Lung 
Cancer Histological Classification of Lung and Pleural Tumors, 
primary pulmonary choriocarcinoma is described as a miscel-
laneous tumor [1]. Primary extragonadal choriocarcinoma is 
very rare and when it occurs, it is usually located in the mid-line 
structures, mainly the retroperitoneum, mediastinum, or cranial 
cavity, although other sites have been reported. One of the least 
common sites is the lung [6]. Large cell carcinoma and pleomor-
phic carcinoma may occasionally include pleomorphic multi-
and/or mononucleated tumor giant cells, which are similar to 
syncytiotrophoblastic cells and cytotrophoblastic cells of cho-
riocarcinoma. This pathological image is sometimes confusing. 
In our case’s histopathological investigation syncytiotrophoblas-
tic and cytotrophoblastic cells were not seen. Giant cells sug-
gesting choriocarcinoma stained positive for germ cell markers 
such as βhCG, HPL and PLAP, but were negative for TTF-1; so 
that tumor was not exactly derived from the lung. In the light of 
these findings this tumor was diagnosed as pleomorphic carci-
noma of the lung with a giant cell component and expressing 
βhCG.
  βhCG is used for detecting and managing gestational tropho-
blastic diseases, diagnosing quiescent gestational trophoblastic 
disease, diagnosing placental site trophoblastic tumor, manag-
ing testicular germ cell malignancies, and monitoring other hu-
man malignancies [7]. βhCG is usually produced in the human 
placenta. Although βhCG synthesis in NSCLC is well-known, 
βhCG producing pleomorphic carcinoma is very rare [8, 12]. 
Thus, to our knowledge this is the third case of pleomorphic 
carcinoma of the lung producing βhCG in the literature. Anoth-
er important issue in our case is, elevated serum βhCG levels 
were associated with clinically significant gynecomastia. Gyne-
comastia is reported in some gonadal and extragonadal origi-
nated cancer types as a paraneoplastic syndrome [9, 10]. But 
again to our knowledge our case is also the first case with gyne-
comastia in pleomorphic carcinoma of the lung. As expected, 
with decreasing levels of βhCG after treatment gynecomastia 
gradually regressed. 
  The association between serum βhCG levels and recurrence 
in patients with lung cancer were previously reported in the lit-
erature [5, 11]. In our patient, βhCG levels decreased after sur-
gery, elevated with recurrence, and decreased again with che-
motherapy. Hirano et al. had suggested that pleomorphic carci-
noma patients with immunohistochemical positivity for βhCG 
have an elevated risk of local recurrence and metastasis [12]. 
Although our patient initially presented with a stage IB tumor, 
recurrence occurred in the postoperative 4th month. Therefore 
elevated βhCG levels may be associated with aggressive clinical 
course and increased risk of recurrence in patients with pleomor-
phic carcinoma expressing βhCG. Furthermore it may have an 
useful role for evaluation of recurrence and therapy response. 
  In patients with lung carcinoma, cases about development of 
cerebral infarct during or after surgical approaches (pneumonec-
tomy or lobectomy) for primary tumor have been reported rare-
ly in the literature. In these cases tumor embolies originating 
from tumor cells disseminating to systemic circulation through 
pulmonary vein in the course of surgical procedures are held 
responsible [13, 14]. Risk factors associated with arterial throm-
boembolism in patients with lung carcinoma are chemotherapy 
(especially cisplatin based) [15], targeted therapy (bevacizum-
ab) [16], tumor induced nonbacterial thrombotic endocarditis 
[17] and disseminated intravascular coagulation [18]. Acute ce-
rebral infarction due to tumor emboly developing after lobec-
tomy for brain metastases was described in a case report [14]. 
However in our case, there were no tumor cells in histopatho-
logical examination of resected cerebral infarct material. Fur-
thermore any of the risk factors related with arterial thrombo-
embolism were absent in our case. In the light of these findings, 
we hypothesize that cerebral thromboembolism may have oc-
curred due to hypercoagulability state associated with the pri-
mary tumor.
  In conclusion, pleomorphic carcinoma is one of the rare tu-
mors of the lung with clinically unpredictable course. Our pa-
tient is the first case of pleomorphic carcinoma of the lung pre-
senting with gynecomastia reported in the literature. Elevated 
βhCG levels may be associated with early recurrence and poor 
prognosis in patients with pulmonary pleomorphic carcinoma.
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